Soleno Therapeutics Inc

Soleno Therapeutics insider sales reveal a tax‑management strategy rather than a warning sign, highlighting executive confidence amid drug launch and legal challenges.

Soleno Therapeutics’ CFO’s fresh insider purchase of shares and warrants shows executive confidence amid a steep stock drop, hinting at upcoming clinical milestones and partnership wins that could revive investor sentiment.